Literature DB >> 33285404

PET/MRI of the hepatobiliary system: Review of techniques and applications.

Preethi Guniganti1, Andrea S Kierans2.   

Abstract

Simultaneous positron emission tomography and MRI (PET/MRI) is an emerging technology that offers the benefits of MRI, including excellent soft tissue contrast, lack of ionizing radiation, and functional MRI techniques, with the physiologic information provided by PET. Although most PET/MRI systems are currently installed in tertiary care centers, PET/MRI technology is becoming increasingly widespread. The usefulness of PET/MRI varies by tumor type and organ system and has been shown to have utility in evaluation of primary and secondary hepatic neoplasms. Understanding the appropriate applications, techniques and relevant imaging findings is important for practicing radiologists considering or currently utilizing PET/MR for the evaluation of primary liver neoplasms, including hepatocellular carcinoma (HCC), as well as staging of biliary neoplasms including cholangiocarcinoma and gallbladder cancer, identification of liver metastases, and staging of neuroendocrine tumor.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dotatate; FDG; HCC; Hepatobiliary; PET/MRI

Year:  2020        PMID: 33285404     DOI: 10.1016/j.clinimag.2020.10.056

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  6 in total

1.  An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Wenjie Miao; Pei Nie; Guangjie Yang; Yangyang Wang; Lei Yan; Yujun Zhao; Ting Yu; Mingming Yu; Fengyu Wu; Wei Rao; Zhenguang Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-04       Impact factor: 9.236

Review 2.  The focus clinical research in intrahepatic cholangiocarcinoma.

Authors:  Yinghui Song; Mengting Cai; Yuhang Li; Sulai Liu
Journal:  Eur J Med Res       Date:  2022-07-11       Impact factor: 4.981

3.  Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma.

Authors:  Gauthier Delaby; Bahar Ataeinia; Jennifer Wo; Onofrio Antonio Catalano; Pedram Heidari
Journal:  Abdom Radiol (NY)       Date:  2021-03-27

4.  Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer.

Authors:  Jun-Jian Yuan; Yan-Dong Xu; Heng Li; Qing-Jin Guo; Guo-Ce Li; Wei Chai; Zhi-Quan Zhang; Ru-Hai Liu
Journal:  J Oncol       Date:  2022-03-30       Impact factor: 4.375

5.  FDG PET-MRI evaluation of synchronous gallbladder adenocarcinoma and POEMS syndrome.

Authors:  Fatemeh Ataei; Akash Sharma; Rupert Stanborough; Ephraim E Parent
Journal:  Radiol Case Rep       Date:  2022-09-13

Review 6.  Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements.

Authors:  Abhilash Perisetti; Hemant Goyal; Rachana Yendala; Ragesh B Thandassery; Emmanouil Giorgakis
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.